Cancer research

Researching the cures of tomorrow for everyone, everywhere

Through innovative research, our experts at Mayo Clinic Comprehensive Cancer Center are creating a future where everyone, everywhere has access to the very best cancer care. We are digging deep to understand what causes cancer in each person, gleaning insights to predict cancer occurrence, and developing new and more-effective treatments. Our researchers are using this discovery knowledge to innovate new methods to detect cancer as early as possible and disrupt its development before it progresses.

Because we tirelessly translate the latest research into better options for patients, people who come to Mayo Clinic for cancer care have first access to the newest, most effective treatments. Our goal is to create personalized treatments for every patient across the disease spectrum — from the earliest stages through advanced and resistant cancers. Breakthrough technologies, such as advanced genetic testing and artificial intelligence, are enabling us to build a future where physicians and scientists can anticipate patient needs and provide personalized tools for prevention, screening, diagnosis, treatment and survivorship.

Prevention and new cures

We are living in an era when expansive data, collected throughout the healthcare journey, can be analyzed by sophisticated computer programs and AI to generate new knowledge. By harnessing this information and technology, we are driving research to prevent cancer, cure more people and improve outcomes for all.

As we work toward a better understanding of the causes of cancer and new cures, we are also transforming how cancer care is delivered. Another research priority is blending virtual, in-facility and at-home treatments to meet our patients where they are, regardless of geographic barriers. Connecting with patients outside the boundaries of traditional hospital walls ensures that we can bring Mayo Clinic's high-quality science and care to underserved communities and improve the lives of people disproportionately affected by health disparities. Our goal is health equity, so that all patients, including those who are vulnerable and underserved, benefit from the most promising advances in modern cancer care.

Advancing care through clinical trials

Experts at Mayo Clinic Comprehensive Cancer Center are advancing cancer care for all through cancer clinical trials. These research studies offer participants earlier access to new treatments and may be the first choice for patients without other treatment options.

By partnering with our diverse communities, we are transforming access to clinical trials and reducing barriers for participation. By involving people from all walks of life, we will reduce the global burden of cancer and improve health equity.

Fulfilling our promise

As a National Cancer Institute (NCI)-Designated Comprehensive Cancer Center we are recognized for our scientific leadership, the depth and breadth of our laboratory and clinical research, and for serving our communities and the public by training and educating cancer researchers and care professionals.

Research conducted at Mayo Clinic Comprehensive Cancer Center aligns with the goals of the National Cancer Plan, which focuses on achieving a society where most cancers are prevented and every person with cancer lives a full and active life.

NCI-Designated Comprehensive Cancer Centers dedicate significant resources to developing research programs, faculty and shared resources that help improve approaches to preventing, diagnosing and treating cancer. We also share evidence-based findings through programs and services tailored to the unique needs and populations of our local communities.